Table Of Content

international journal of pharmaceutics si RAY tt i‘ LSEVIER International Journal of Pharmaceutics 120 (1995) 255-256 Author Index Acar, L., see Sarciaux, J.M. (120) 127 Feijen, J., see Cremers, H.F.M. (120) 51 Am Ende, M.T., Bell, C.L., Peppas, N.A., Massimo, G. and Fernandez-Hervas, M.J., see Holgado, M.A. (120) 157 Colombo, P. Fini, A., see Holgado, M.A. (120) 157 Measurement of the swelling force in ionic polymeric networks: II. Swelling force and disintegration of con- Gavach, C., see Raffin, F. (120) 205 trolled release dosage formulations using pH-sensitive Gonzalez, A.G., Herrador, M.A. and Asuero, A.G. components (120) 33 Hydrophobicity of B-adrenoceptor blocking agents: Study Asuero, A.G., see Gonzalez, A.G. (120) 215 of correlations between retention in reversed-phase HPLC systems and octanol-water partition constants (120) 215 Bae, Y.H., see Cremers, H.F.M. (120) 51 Griesser, U.J. and Burger, A. Barzegar-Jalali, A., see Barzegar-Jalali, M. (120) 111 The effect of water vapor pressure on desolvation kinetics of caffeine 4/5-hydrate (120) 83 Barzegar-Jalali, M. and Barzegar-Jalali, A. Guillory, J.K., see Roy, A.K. (120) 169 Bioavailability determination for drugs exhibiting variable renal excretion rate constant between treatments (120) 111 Guyot, J.C., see Nokhodchi, A. (120) 13 Bayon, L.G., see Cremers, H.F.M. (120) 51 Hanchard, C., see Jadoul, A. (120) 221 Bell, C.L., see Am Ende, M.T. (120) 33 Hartner, K.C., see Imanidis, G. (120) 41 Burger, A., see Griesser, U.J. (120) 83 Herrador, M.A., see Gonzalez, A.G. (120) 215 Heuff, G., see Cremers, H.F.M. (120) 51 Chapman, S.R., see Newton, J.M. (120) 95 Hirsch, R. and Miller-Goymann, C.C. Chapman, S.R., see Newton, J.M. (120) 101 Fitting of diffusion coefficients in a three-compartment Chattaraj, S.C., Swarbrick, J. and Kanfer, I. sustained release drug formulation using a genetic algo- A simple diffusion cell to monitor drug release from rithm (120) 229 semi-solid dosage forms (120) 119 Holgado, M.A., Fernandez-Hervas, M.J., Rabasco, A.M. and Chen, C.-Y., see Cheng, H.-W. (120) 137 Fini, A. Chen, F.-A., see Cheng, H.-W. (120) 137 Characterization study of a diclofenac salt by means of Cheng, H.-W., Chen, F.-A., Hsu, H.-C. and Chen, C.-Y. SEM and fractal analysis (120) 157 Photochemical decomposition of alkannin/shikonin enan- Hsu, H.-C., see Cheng, H.-W. (120) 137 tiomers (120) 137 Colombo, P., see Am Ende, M.T. (120) 33 Imanidis, G., Hartner, K.C. and Mazer, N.A. Cremers, H.F.M., Verrijk, R., Bayon, L.G., Wesseling, M.M., Intestinal permeation and metabolism of a model peptide Wondergem, J., Heuff, G., Meijer, S., Kwon, G.S., Bae, (leuprolide) and mechanisms of permeation enhancement Y.H., Kim, S.W. and Feijen, J. by non-ionic surfactants (120) 41 Improved distribution and reduced toxicity of adriamycin bound to albumin-heparin microspheres (120) 51 Jacob, M., see Raffin, F. (120) 205 Jadoul, A., Hanchard, C., Thysman, S. and Préat, V. Dayter, L., see Randall, C.S. (120) 235 Quantification and localization of fentanyl and TRH deliv- DiNenno, B.K., see Randall, C.S. (120) 235 ered by iontophoresis in the skin (120) 221 Duchene, D., see Skiba, M. (120) 1 Duncan, M.R., Lee, J.M. and Warchol, M.P. Kanfer, I., see Chattaraj, $.C. (120) 119 Influence of surfactants upon protein /peptide adsorption Kim, C.-K., Yoon, Y.-S. and Kong, J.Y. to glass and polypropylene (120) 179 Preparation and evaluation of flurbiprofen dry elixir as a Duru, C., see Raffin, F. (120) 205 novel dosage form using a spray-drying technique (120) 21 256 Author Index Kim, S.W., see Cremers, H.F.M. (120) 51 Rowe, R.C., see Newton, J.M. (120) 101 Kinget, R., see Talukdar, M.M. (120) 63 Roy, A.K. and Guillory, J.K. Kong, J.Y., see Kim, C.-K. (120) 21 The kinetics and mechanism of the hydrolysis of cyclopen- Konieczny, M., see Randall, C.S. (120) 235 tolate hydrochloride in alkaline solutions (120) 169 Kwon, G.S., see Cremers, H.F.M. (120) 51 Rubinstein, M.H., see Nokhodchi, A. (120) 13 Larhrib, H., see Nokhodchi, A. (120) 13 Sado, P.A., see Sarciaux, J.M. (120) 127 Lee, H.K., see Stella, V.J. (120) 189 Sandeaux, J., see Raffin, F. (120) 205 Lee, H.K., see Stella, V.J. (120) 197 Sandeaux, R., see Raffin, F. (120) 205 Lee, J.M., see Duncan, M.R. (120) 179 Sarciaux, J.M., Acar, L. and Sado, P.A. Using microemulsion formulations for oral drug delivery Massimo, G., see Am Ende, M.T. (120) 33 of therapeutic peptides (120) 127 Mazer, N.A., see Imanidis, G. (120) 41 Schultz, R.K., see Randall, C.S. (120) 235 Meijer, S., see Cremers, H.F.M. (120) 51 Singla, A.K. and Wadhwa, H. Miiller-Goymann, C.C., see Hirsch, R. (120) 229 Zinc-indomethacin complex: synthesis, physicochemical and biological evaluation in the rat (120) 145 Naisbett, B. and Woodley, J. Sistat, P., see Raffin, F. (120) 205 The potential use of tomato lectin for oral drug delivery: 4. Skiba, M., Puisieux, F., Duchene, D. and Wouessidjewe, D. Immunological consequences (120) 247 Direct imaging of modified B-cyclodextrin nanospheres by Naon, R., see Privitera, N. (120) 73 photon scanning tunnelling and scanning force microscopy Newton, J.M., Chapman, S.R. and Rowe, R.C. (120) 1 The assessment of the scale-up performance of the extru- Stella, V.J., Lee, H.K. and Thompson, D.O. sion /spheronisation process (120) 95 The effect of SBE4-8-CD on i.m. prednisolone pharma- Newton, J.M., Chapman, S.R. and Rowe, R.C. cokinetics and tissue damage in rabbits: Comparison to a The influence of process variables on the preparation and co-solvent solution and a water-soluble prodrug (120) 197 properties of spherical granules by the process of extrusion Stella, V.J., Lee, H.K. and Thompson, D.O. and spheronisation (120) 101 The effect of SBE4-8-CD on i.v. methylprednisolone phar- Nokhodchi, A., Rubinstein, M.H., Larhrib, H. and Guyot, J.C. macokinetics in rats: Comparison to a co-solvent solution The effect of moisture content on the energies involved in and two water-soluble prodrugs (120) 189 the compaction of ibuprofen (120) 13 Swarbrick, J., see Chattaraj, S.C. (120) 119 Panduranga Rao, K., see Thacharodi, D. (120) 115 Talukdar, M.M. and Kinget, R. Peppas, N.A., see Am Ende, M.T. (120) 33 Swelling and drug release behaviour of xanthan gum ma- Pourcelly, G., see Raffin, F. (120) 205 trix tablets (120) 63 Préat, V., see Jadoul, A. (120) 221 Thacharodi, D. and Panduranga Rao, K. Privitera, N., Naon, R., Vierling, P. and Riess, J.G. Collagen-chitosan composite membranes for controlled re- Phagocytic uptake by mouse peritoneal macrophages of lease of propranolol hydrochloride (120) 115 microspheres coated with phosphocholine or polyethylene Thompson, D.O., see Stella, V.J. (120) 189 glycol phosphate-derived perfluoroalkylated surfactants Thompson, D.O., see Stella, V.J. (120) 197 (120) 73 Thysman, S., see Jadoul, A. (120) 221 Puisieux, F., see Skiba, M. (120) 1 Verrijk, R., see Cremers, H.F.M. (120) 51 Rabasco, A.M., see Holgado, M.A. (120) 157 Vierling, P., see Privitera, N. (120) 73 Raffin, F., Duru, C., Jacob, M., Sistat, P., Sandeaux, J., Sandeaux, R., Pourcelly, G. and Gavach, C. Wadhwa, H., see Singla, A.K. (120) 145 Physico-chemical characterization of the ionic permeabil- Warchol, M.P., see Duncan, M.R. (120) 179 ity of an enteric coating polymer (120) 205 Wesseling, M.M., see Cremers, H.F.M. (120) 51 Randall, C.S., DiNenno, B.K., Schultz, R.K., Dayter, L., Wondergem, J., see Cremers, H.F.M. (120) 51 Konieczny, M. and Wunder, S.L. Woodley, J., see Naisbett, B. (120) 247 Solid-state transformation of a leukotriene antagonist (120) Wouessidjewe, D., see Skiba, M. (120) 1 235 Wunder, S.L., see Randall, C.S. (120) 235 Riess, J.G., see Privitera, N. (120) 73 Rowe, R.C., see Newton, J.M. (120) 95 Yoon, Y.-S., see Kim, C.-K. (120) 21